Flower buds of Lonicera japonica THUNB. (Caprifoliaceae), one of the most common traditional Chinese medicines, are used to treat various diseases including arthritis, diabetes mellitus, fever, infections, sores and swelling.
Pharmacological studies have indicated that the extract of these flower buds have a broad spectrum of biological activities, including antibacterial, anti-inflammatory, antioxidant, antipyretic, antiviral and hepato-protective effects. 1, 2) A number of chemical constituents including flavonoids, iridoids and saponins have been obtained from this plant. [3] [4] [5] [6] [7] [8] In our continuing search for allergy-preventive substances from natural sources, 9) we have been using our previously developed in vivo assay method to estimate effects on complex allergies. 10, 11) This time, we found that the 35% EtOH extract of flower buds of L. japonica exhibited allergy-preventive activity. Our in vivo assay method monitors the decrease in blood flow (BF) in the tail vein of mice subjected to hen eggwhite lysozyme (HEL) sensitization alone without the HELchallenge as a guide.
10) The BF in HEL-sensitized mice (control group) gradually and significantly decreased to about 70% of that in normal mice on day 9. Thus, the induction phase (promotion stage) of allergy caused by xenobiotics can be dynamically and easily measured using BF monitoring. This BF decrease is considered to be due to the contraction of peripheral blood vessels and an increase in blood viscosity, because no relationship with blood pressure was observed. Although anti-HEL immunoglobulin E (IgE) antibody significantly increased after HEL sensitization, there was no significant increase in the number of leukocytes. Thus, a decrease in BF reflects the promoter process of an allergic reaction. The BF decrease is regulated by various factors such as nitric oxide (NO), thromboxane (TX) A 2 , prostacyclin (PGI 2 ), and endothelin (ET)-1, together with granulocytic elastase (GE), cyclooxygenase (COX)-1 and -2, inducible nitric oxide synthase (iNOS), and constitutive nitric oxide synthase (cNOS). 10) In addition, the BF decrease occurs via both pathways of iNOS-independent and -dependent responses.
11) Therefore this monitoring system should be useful when searching for substances that can prevent complicated inflammatory allergies involving NO, TXA 2 , PGI 2 , ET-1, GE, COX-1, and COX-2. This paper describes the evaluation of the allergy-preventive effects of a 35% EtOH extract (LJ) of flower buds of L. japonica and the following compounds isolated from LJ: chlorogenic acid (1) and three iridoid derivatives, loganin (2), secoxyloganin (3) and sweroside (4).
The structure-activity relationships of iridoid derivatives, morroniside (5), geniposide (6), asperuloside (7), aucubin (8) and catalpol (9) were also examined, as iridoid glucosides (2-4) isolated from LJ showed allergy-preventive effects.
MATERIALS AND METHODS

General Experimental Procedures
Melting points were determined on a Yanagimoto micro-point apparatus. IR spectra were recorded on a Shimadzu 435 spectrometer and 1 Hand 13 C-NMR spectra were recorded with a JEOL JEM-GSX 500 spectrometer (tetramethylsilane (TMS) as internal reference). FAB-MS were performed on a JMS-700 double-focusing mass spectrometer having a kinetic energy equivalent to 6 kV at an ion-acceleration voltage of 3 kV. The mass marker was calibrated with perfluoroalkylphosphazine (ultra marker), and 3-nitrobenzyl alcohol (NBA) and glycerin (GLY) were used as the matrix.
Plant Materials Flower buds of L. japonica (common name: Kinginka) were purchased from Tochimoto Tenkaido Co., Ltd. A voucher specimen is kept at our university. Compounds 5-9 had been previously isolated in our laboratory. HEL Sensitization Immunization with hen egg-white lysozyme (HEL) was performed as previously described 12) with slight modification. Male ddY mice of 5 weeks of age were sensitized interperitoneally with 50 mg of HEL in complete Freund's adjuvant (DIFCO) on day 0.
Extraction and Isolation Procedures
Blood Flow Measurement The BF in the mouse tail vein was monitored using a laser doppler blood flow meter of the contact type (OMEGA FLO-C1 Neuroscience Inc., Tokyo, Japan) as previously described. 10) Each mouse was pre-warmed for 10 min at 36°C prior to the experiment and placed on a holder in a measuring chamber kept at 36°C throughout the measurement. The normal BF was measured for 10 min at 1 d before the experiment. The BF of the sensitized mouse was measured for 10 min without anesthesia. The results were expressed as meanϮS.E. of the percent of the normal BF of each mouse.
In Vivo Assay Method of Allergy-Preventive Activity Each extract (100 or 200 mg/kg) and compound (10 mg/kg) was dissolved in water and administered (10 ml of test solution/g body weight) orally to HEL-sensitized mice at 0 (the start day), 3, 6 and 9 d. None of the reagents affected the BF. The measurements of BF were carried out every day for 9 d. The statistical calculations were determined in comparison with the HEL-sensitized mice (control group).
Platelet Aggregation The platelet aggregation of whole blood induced by ADP (8 mM) was measured with a whole blood aggregometer (WBA) analyzer (MC Medical Co., Ltd., Tokyo, Japan) using a screen filtration pressure (SFP) method. The whole blood was obtained from each anesthetized mouse with diethyl ether on day 9. The samples were anticoagulated with 3.8% sodium citrate and then left to stand for 30 min at room temperature for stable aggregation (nϭ5).
Statistical Analysis Two-way analysis of variance (ANOVA) was used to test for statistical differences. When significant differences (pϽ0.05) were identified, the data were further analyzed by Dunnett's multiple range test with Bonferroni inequality for significant differences between each test group and the control group.
RESULTS
Isolation and Identification of Compounds
Compounds 1-4 were isolated from LJ by successive chromatography. The structures of these known compounds were identified as chlorogenic acid (1), 13) loganin (2), 14) secoxyloganine (3), 15) and sweroside (4), 14) by comparison of their physical and spectroscopic data (MS, UV, IR, 1 H-and 13 C-NMR) with the literature values. These compounds were subjected to the bioassay.
Effects of Extracts and Isolated Compounds on BF Decrease in Response to HEL
The BF in the tail vein of HEL-sensitized mice (control group) gradually and significantly decreased to ca. 70% of the BF of normal mice at day 9, as shown in Fig. 1 . On the other hand, oral administration (per os (p.o.)) of LJ (200 mg/kg) significantly (pϽ0.05) inhibited the BF decrease compared with the control group after day 6 of HEL-sensitization. Figure 2 shows the effects of AcOEt, n-BuOH and H 2 O ext. fractionated from LJ. The H 2 O ext. at 200 mg/kg (p.o.) significantly inhibited the BF decrease after day 8 of HELsensitization, but AcOEt ext. and n-BuOH ext. did not. Figure 3 shows the effects of Fr. Ia-d fractionated from the most active H 2 O extract at 100 mg/kg (p.o.). Fr. Ib (-᭡-), c (-᭝-) and d (-ᮀ-) significantly (pϽ0.05) inhibited the BF decrease compared with the control group after day 7 of HEL-sensitization. Figure 4 shows the effects of compounds 1-4 isolated from Fr. IIb and IIe fractionated from the active Fr. Ib. All Chart 1 compounds significantly (pϽ0.05) inhibited the BF decrease at 10 mg/kg (p.o.) compared with the control group after day 6 or 7 of HEL-sensitization. The molecular weight of these compounds 1-4 are about the same, and 10 mg/kg is equivalent to 1: 28, 2: 26, 3: 26 and 4: 28 mmol/kg. Figure 5 shows the effects of the major compound 1 at 20 mg/kg (p.o.) and epinastine hydrochloride, which is used clinically as an anti-allergic medicine, at 5 mg/kg (p.o.) as a positive control. Both compounds showed almost the same activity and significantly (pϽ0.05) inhibited the BF decrease after day 6 of HEL-sensitization.
Platelet Aggregation Effects of Isolated Compounds
To examine the inhibition mechanism of the BF decrease, the platelet aggregation effects of Fr. 1a-d at 100 mg/kg (p.o.) and compounds 1-4 at 10 mg/kg (p.o.) were examined. All fractions and compounds showed no inhibition of platelet aggregation when compared with the control group (data not shown).
Structure-Activity Relationships of Iridoid Glucoside Derivatives
The results of Fig. 4 indicate the possibility that other iridoid derivatives may also show allergy-preventive effects. Therefore, we also tested five other iridoid glucosides, morroniside (5), geniposide (6), asperuloside (7), aucubin (8) and catalpol (9) , to examine the structure-activity relationship, using the same methods.
Significant inhibition of BF was noted with 10 mg/kg of compounds 5 and 9 (Figs. 6a, c ), but none with compounds 6, 7, 8, which have a double bond at C-7, C-8 (Figs. 6b, c) . The molecular weights of iridoid glucosides 2-9 are about the same.
DISCUSSION
In this study, we investigated the allergy-preventive effects of LJ and isolated compounds using our previously developed in vivo assay method which can be used to estimate complex allergy effects. 10, 11) LJ significantly inhibited the BF decrease compared with the control group (Fig. 1) , suggesting that it possessed allergy-preventive effects.
Bioassay-guided fractionation led to four known com- (Fig. 4) . These compounds have been isolated from many plants, and many of their bioactivities, including anti-inflammatory, anti-allergic, and antiasthmatic effects, have been reported. [16] [17] [18] [19] However, this is the first report of their allergy-preventive effects in the induction phase of an allergy. Among them chlorogenic acid (1) is regarded as an active substance of LJ, since 1 is a major constituent of the extract. These results suggested that 1 inhibits the BF decrease by inhibitory mechanisms on (i) expression of nuclear factor kappa B (NF-kB), iNOS and COX-2, [20] [21] [22] [23] [24] (ii) enzyme activity of iNOS and elastase, 24, 25) (iii) increased platelet aggregation, and (iv) expression of TXA 2 .
26) It is interesting that secoiridoids 2 and 3 showed allergy-preventive activity, because there has been only one report on the anti-allergic activity of secoiridoids, which showed an inhibitory effect on histamine release from rat mast cells. 27) In a previous study, we found that some flavanones and chalcones from Xanthorrhoea hastilis significantly inhibited BF decrease, with inhibitory mechanisms involving platelet aggregation inhibition. 28) However, iridoid compounds 2-4 did not inhibit platelet aggregation, indicating a different inhibition mechanism on the BF decrease. There have been many reports on the anti-allergic effects of iridoid derivatives which inhibit the production of COX-2 29) or NO, 30) or the expression of iNOS and COX-2. 31) Inhibition of the BF decrease by iridoid derivatives may occur in a similar manner. Details of the mode of action of LJ and the isolated compounds are under investigation.
We also examined the structure-activity relationship of iridoid derivatives with other iridoids 5-8. Compounds 5 and 9 showed significant inhibition of the BF decrease, whereas compounds 6, 7 and 8 did not. Thus, compounds 2-5 and 9 having the sp 3 atom at C-8 are active, while compounds having a double bond at C-7, C-8 do not show the allergypreventive effect. Compound 9, the most active, has been reported as an anti-inflammatory medicine which possesses therapeutic potential against LPS-induced acute systemic inflammation by attenuating NF-kB activation. 32) Further results will be reported elsewhere. 
